The efficiency frontier approach to economic evaluation of health-care interventions
Background: IQWiG commissioned an international panel of experts to develop methods for the assessment of the relation of benefits to costs in the German statutory health-care system. Proposed methods: The panel recommended that IQWiG inform German decision makers of the net costs and value of additional benefits of an intervention in the context of relevant other interventions in that indication. To facilitate guidance regarding maximum reimbursement, this information is presented in an efficiency plot with costs on the horizontal axis and value of benefits on the vertical. The efficiency frontier links the interventions that are not dominated and provides guidance. A technology that places on the frontier or to the left is reasonably efficient, while one falling to the right requires further justification for reimbursement at that price. This information does not automatically give the maximum reimbursement, as other considerations may be relevant. Given that the estimates are for a specific indication, they do not address priority setting across the health-care system. Conclusion: This approach informs decision makers about efficiency of interventions, conforms to the mandate and is consistent with basic economic principles. Empirical testing of its feasibility and usefulness is required. Copyright © 2010 John Wiley & Sons, Ltd.
Volume (Year): 19 (2010)
Issue (Month): 10 ()
|Contact details of provider:|| Web page: http://www3.interscience.wiley.com/cgi-bin/jhome/5749|
References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Zuckerman, Stephen & Hadley, Jack & Iezzoni, Lisa, 1994. "Measuring hospital efficiency with frontier cost functions," Journal of Health Economics, Elsevier, vol. 13(3), pages 255-280, October.
- Dorte Gyrd-Hansen, 2005. "Willingness to Pay for a QALY: Theoretical and Methodological Issues," PharmacoEconomics, Springer Healthcare | Adis, vol. 23(5), pages 423-432.
- Dan Horsky & Paul Nelson, 1996. "Evaluation of Salesforce Size and Productivity Through Efficient Frontier Benchmarking," Marketing Science, INFORMS, vol. 15(4), pages 301-320.
- Christopher McCabe & Karl Claxton & Anthony J. Culyer, 2008.
"The NICE Cost-Effectiveness Threshold: What it is and What that Means,"
Springer Healthcare | Adis, vol. 26(9), pages 733-744.
- McCabe, C & Claxton, K & Culyer, AJ, 2008. "The NICE Cost-Effectiveness Threshold: What it is and What that Means," MPRA Paper 26466, University Library of Munich, Germany.
- Erik Nord & Jose Luis Pinto & Jeff Richardson & Paul Menzel & Peter Ubel, 1999. "Incorporating societal concerns for fairness in numerical valuations of health programmes," Health Economics, John Wiley & Sons, Ltd., vol. 8(1), pages 25-39.
- Johnes, Jill & Johnes, Geraint, 1995. "Research funding and performance in U.K. University Departments of Economics: A frontier analysis," Economics of Education Review, Elsevier, vol. 14(3), pages 301-314, September.
When requesting a correction, please mention this item's handle: RePEc:wly:hlthec:v:19:y:2010:i:10:p:1117-1127. See general information about how to correct material in RePEc.
If references are entirely missing, you can add them using this form.